European Journal of Surgical Oncology
Volume 34, Issue 6 , Pages 636-641 , June 2008

Tissue inhibitor of metalloproteinase-2 G-418C polymorphism is associated with an increased risk of gastric cancer in a Chinese population

  • L. Yang

      Affiliations

    • Key Laboratory of Reproductive Medicine, Department of Pharmacology, Nanjing Medical University, 140 Hanzhong Road, Nanjing 210029, Jiangsu Province, China
    • Department of General Surgery, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China
    • These authors have contributed equally to this work.
    • ,
  • H.-J. Gu

      Affiliations

    • Key Laboratory of Reproductive Medicine, Department of Pharmacology, Nanjing Medical University, 140 Hanzhong Road, Nanjing 210029, Jiangsu Province, China
    • These authors have contributed equally to this work.
    • ,
  • H.-J. Zhu

      Affiliations

    • Key Laboratory of Reproductive Medicine, Department of Pharmacology, Nanjing Medical University, 140 Hanzhong Road, Nanjing 210029, Jiangsu Province, China
    • These authors have contributed equally to this work.
    • ,
  • Q.-M. Sun

      Affiliations

    • Key Laboratory of Reproductive Medicine, Department of Pharmacology, Nanjing Medical University, 140 Hanzhong Road, Nanjing 210029, Jiangsu Province, China
    • ,
  • R.-H. Cong

      Affiliations

    • Key Laboratory of Reproductive Medicine, Department of Pharmacology, Nanjing Medical University, 140 Hanzhong Road, Nanjing 210029, Jiangsu Province, China
    • ,
  • B. Zhou

      Affiliations

    • Key Laboratory of Reproductive Medicine, Department of Pharmacology, Nanjing Medical University, 140 Hanzhong Road, Nanjing 210029, Jiangsu Province, China
    • ,
  • N.-P. Tang

      Affiliations

    • Key Laboratory of Reproductive Medicine, Department of Pharmacology, Nanjing Medical University, 140 Hanzhong Road, Nanjing 210029, Jiangsu Province, China
    • ,
  • B. Wang

      Affiliations

    • Key Laboratory of Reproductive Medicine, Department of Pharmacology, Nanjing Medical University, 140 Hanzhong Road, Nanjing 210029, Jiangsu Province, China
    • Corresponding Author InformationCorresponding author. Department of Pharmacology, Nanjing Medical University, 140 Hanzhong Road, Nanjing 210029, Jiangsu Province, China. Tel./fax: +86 25 86862884.

,Accepted 4 September 2007.

References 

  1. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2:16174
  2. Monig SP, Baldus SE, Hennecken JK, et al. Expression of MMP-2 is associated with progression and lymph node metastasis of gastric carcinoma. Histopathology. 2001;39:597–602
  3. Howard EW, Bullen EC, Banda MJ. Preferential inhibition of 72- and 92-kDa gelatinase by tissue inhibitor of metalloproteinases-2. J Biol Chem. 1991;266:13070–13075
  4. Jiang Y, Goldberg ID, Shi YE. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene. 2002;21:2245–2252
  5. Hirano K, Sakamoto T, Uchida Y, et al. Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease. Eur Respir J. 2001;18:748–752
  6. De Clerck YA, Darville MI, Eeckhout Y, Rousseau GG. Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinase-2 (TIMP-2). Gene. 1994;139:185–191
  7. Kang HS, Kim SK, Cho BK, Kim YY, Hwang YS, Wang KC. Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial moyamoya disease. Neurosurgery. 2006;58:1074–1080
  8. Chen D, Wang Q, Ma ZW, et al. MMP-2, MMP-9 and TIMP-2 gene polymorphisms in Chinese patients with generalized aggressive periodontitis. J Clin Periodontol. 2007;34:384–389
  9. de Souza AP, Trevilatto PC, Scarel-Caminaga RM, de Brito RB, Barros SP, Line SR. Analysis of the MMP-9 (C-1562T) and TIMP-2 (G-418C) gene promoter polymorphisms in patients with chronic periodontitis. J Clin Periodontol. 2005;32:207–211
  10. Vairaktaris E, Yapijakis C, Yiannopoulos A, et al. Strong association of the tissue inhibitor of metalloproteinase-2 polymorphism with an increased risk of oral squamous cell carcinoma in Europeans. Oncol Rep. 2007;17:963–968
  11. O-Charoenrat P, Khantapura P. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer. Oral Oncol. 2006;42:257–267
  12. Zhou Y, Yu C, Miao X, et al. Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes. Carcinogenesis. 2004;25:399–404
  13. Wu CY, Wu MS, Chen YJ, et al. Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer. Eur J Cancer. 2007;43:799–808
  14. Kubben FJ, Sier CF, Meijer MJ, et al. Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. Br J Cancer. 2006;95:744–751
  15. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108
  16. Zhu H, Yang L, Zhou B, Yu R, Tang N, Wang B. Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case–control study. Carcinogenesis. 2006;27:2491–2496
  17. Wang B. Major causes of death in China. N Engl J Med. 2006;354:874–875
  18. Wang B, Pan J, Wang L, Zhu H, Yu R, Zou Y. Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease. Atherosclerosis. 2006;184:425–430
  19. In:  Sobin LH,  Wittekind CH editor. TNM classification of malignant tumors. 5th ed.. New York: Wiley & Sons, Inc.,; 1997;p. 59–62
  20. Baker AH, Edwards DR, Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci. 2002;115:3719–3727
  21. Brand K, Baker AH, Perez-Canto A, et al. Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissues. Cancer Res. 2000;60:5723–5730
  22. Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003;9:653–660
  23. Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A. Cell growth promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci. 1994;107:2373–2379
  24. Wang Z, Juttermann R, Soloway PD. TIMP-2 is required for efficient activation of proMMP-2 in vivo. J Biol Chem. 2000;275:26411–26415
  25. Parkin DM. International variation. Oncogene. 2004;23:6329–6340
  26. Valenca SS, Castro P, Pimenta WA, et al. Light cigarette smoke-induced emphysema and NFkappaB activation in mouse lung. Int J Exp Pathol. 2006;87:373–381
  27. Murray GI, Duncan ME, Arbuckle E, Melvin WT, Fothergill JE. Matrix metalloproteinases and their inhibitors in gastric cancer. Gut. 1998;43:791–797
  28. Bramhall SR, Hallissey MT, Whiting J, et al. Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial. Br J Cancer. 2002;86:1864–1870

PII: S0748-7983(07)00532-X

doi: 10.1016/j.ejso.2007.09.003

European Journal of Surgical Oncology
Volume 34, Issue 6 , Pages 636-641 , June 2008

Article Tools

* Image Usage & Resolution